Catherine is an Analyst in the Responsible Investment team. She joined Columbia Threadneedle through the acquisition of BMO GAM (EMEA) in 2021, having previously been with BMO since 2015. Before joining the Responsible Investment (RI) team in 2018, she was a Product Specialist for the Emerging Market Debt team in London. She works on Responsible and Sustainable strategies, regulation (including SFDR and SDR) and its impact on investment frameworks, and leverages the expertise of external Councils to guide the RI team's strategy. She previously covered healthcare companies and public health issues, including antimicrobial resistance. Catherine has passed Level I of the CFA program and graduated from the University of Oxford with a degree in Modern Languages (German and Italian).